EIF4E2 / 4EHP (O60573) research notes

eIF4E homologous protein (4EHP). Class II eIF4E-family cap-binding protein.

Core function: non-canonical cap binding that REPRESSES initiation

4EHP binds the m7G cap but cannot recruit eIF4G, so it competes with eIF4E and blocks
eIF4F assembly, repressing cap-dependent translation initiation.

4EHP-GIGYF2 module + RQC

UniProt: "Component of the 4EHP-GYF2 complex ... In association with GIGYF2, assists
ribosome-associated quality control (RQC) by sequestering the mRNA cap, blocking ribosome
initiation and decreasing the translational load on problematic messages."
[PMID:32726578 RQC; PMID:22751931 development].

miRNA silencing via CCR4-NOT / P-body

PMID:28487484 Also controls IFNB1 via miR-34a negative feedback. P-body localization.

SARS-CoV-2

nsp2-GIGYF2 enhances GIGYF2-EIF4E2 binding to repress IFNB1 translation PMID:35878012.

Ubiquitylation by HHARI

PMID:14623119 -> GO:0031625 ubiquitin protein ligase
binding (HHARI/ARIH1). Real interaction.

IMPORTANT annotation caveats

Core MF/BP for review

Evidence re-review, 2026-09-20

Reviewed all 44 annotation rows against available primary interaction, cap-binding, translation, localization and quality-control studies and PAINT PTHR11960/PTN000238660. The earlier notes' assertion that EIF4E2 cannot recruit eIF4G was too broad. PMID:22678294 and full-text PMID:26854219 establish hypoxic translation and an EIF4E2/eIF4A/eIF4G3 complex. Restored translation-initiation factor, initiation process and eIF4F-complex rows; updated description and core functions. These roles coexist with GIGYF/4E-T-mediated repression. Current GO:0072344 requires release of an already stalled ribosome, whereas PMID:32726578 demonstrates suppressing additional rounds of initiation alongside RQC; its annotation was modified to negative regulation of initiation. The generated PN notes are historical context and were not rewritten. A neutral independent adjudication of the dual initiation/repression roles was requested through the coordinator; no duplicate report was launched. New primary source: PMID:26854219(https://pubmed.ncbi.nlm.nih.gov/26854219/).

2026-09-21: focused eIF4F report incorporated; older categorical statements superseded

The earlier statements that EIF4E2 cannot form a productive eIF4F complex or cannot associate with any eIF4G paralog are too broad. PMID:26854219 full-text Results and Fig2C/S2D report endogenous human EIF4E2/eIF4A/eIF4G3 pull-downs, with eIF4G3 depletion impairing hypoxic translation and polysome recruitment. PMID:22678294 explicitly reports eIF4A recruitment. These primary observations support the retained GO:0016281 complex annotation and hypoxic initiation function alongside GIGYF-mediated repression; no new ribosome-binding claim is inferred from polysome association.

Read the entire eif4f-complex-under-hypoxia/openscientist.md report and its plot provenance JSON. It supports context-dependent initiation and repression but incorrectly treats complex composition as untested. Lack of a separately curated Complex Portal entry or experimental GO row is not a negative assay. PMID:28698298 analyzes GIGYF/4E-BP interfaces and cites earlier work for lack of eIF4G interaction; it does not test hypoxic EIF4G3 complex assembly. Its dorsal partner-binding surface lies opposite the cap pocket, contrary to the report's conflation of cap-stacking Trp/Tyr with a proposed dorsal binding defect. Binary binding and complex membership are separate questions.

Delivered plot code hard-codes claimed alignment identities and labels IBA/ISS 'weak'; it supplies no reproducible alignment supporting those numerical claims. They are not adopted as independently verified sequence results. The report is marked DISPUTED, while its supported dual-function findings are incorporated. The complex annotation stays ACCEPT; no new broad or redundant process annotation is added.